Editor’s note: This is a developing news story. Please check back soon for updates.
In a pivotal clinical trial, an excimer laser procedure reduced IOP in patients with glaucoma, according to a press release from Bausch + Lomb.
The Elios system reduced patients’ IOP by creating microchannels in the trabecular meshwork to improve aqueous flow.
Researchers conducted a prospective study including 318 patients at 20 U.S. sites who were previously diagnosed with mild to moderate primary open-angle glaucoma, for which they were taking glaucoma medications, and cataracts. The co-primary endpoints